AUDREY MARTINEZ: Open Payments
NPI 1811695158 · BEAUMONT, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$725 in 30 payments from 9 companies in 2025. Trend: 2023 $88 · 2024 $213 · 2025 $725
Food & beverage: $553Education: $172
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $277 |
| Novartis Pharmaceuticals Corporation | 6 | $126 |
| ABBVIE INC. | 4 | $97 |
| Lilly USA, LLC | 3 | $82 |
| GENZYME CORPORATION | 2 | $44 |
| PFIZER INC. | 2 | $39 |
| Arcutis Biotherapeutics, Inc. | 1 | $22 |
| Galderma Laboratories, L.P. | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
Products named: TREMFYA, RINVOQ, EBGLYSS, COSENTYX, DUPIXENT, Rhapsido, CIBINQO, Zoryve.
Industry payments across TX — which companies pay providers there.
